These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 20734401)
1. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma. Moore C; Eslin D; Levy A; Roberson J; Giusti V; Sutphin R Pediatr Blood Cancer; 2010 Dec; 55(6):1096-102. PubMed ID: 20734401 [TBL] [Abstract][Full Text] [Related]
2. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma. De Angulo G; Hernandez M; Morales-Arias J; Herzog CE; Anderson P; Wolff J; Kleinerman ES J Pediatr Hematol Oncol; 2007 Jan; 29(1):48-52. PubMed ID: 17230066 [TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809 [TBL] [Abstract][Full Text] [Related]
4. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968 [TBL] [Abstract][Full Text] [Related]
5. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647 [TBL] [Abstract][Full Text] [Related]
7. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma. Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458 [TBL] [Abstract][Full Text] [Related]
8. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Hawkins DS; Arndt CA Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080 [TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502 [TBL] [Abstract][Full Text] [Related]
12. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Porrata LF; Gertz MA; Litzow MR; Lacy MQ; Dispenzieri A; Inwards DJ; Ansell SM; Micallef IN; Gastineau DA; Elliott M; Hogan WJ; Hayman SR; Tefferi A; Markovic SN Clin Cancer Res; 2005 Feb; 11(3):1210-8. PubMed ID: 15709191 [TBL] [Abstract][Full Text] [Related]
13. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627 [TBL] [Abstract][Full Text] [Related]
14. Childhood osteosarcoma: multimodal therapy in a single-institution Turkish series. Ayan I; Kebudi R; Ozger H Cancer Treat Res; 2009; 152():319-38. PubMed ID: 20213399 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Kim H; Sohn HJ; Kim SE; Kang HJ; Park S; Kim S; Kim WK; Lee JS; Suh C Bone Marrow Transplant; 2004 Jul; 34(1):43-9. PubMed ID: 15107814 [TBL] [Abstract][Full Text] [Related]
16. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Crompton BD; Goldsby RE; Weinberg VK; Feren R; O'Donnell RJ; Ablin AR Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980 [TBL] [Abstract][Full Text] [Related]
17. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175 [TBL] [Abstract][Full Text] [Related]
18. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Bacci G; Longhi A; Cesari M; Versari M; Bertoni F Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma. Tiwari D; Gao F; Hidalgo J; Adkins DR; Vij R; DiPersio JF; Khoury HJ Bone Marrow Transplant; 2007 Oct; 40(7):671-5. PubMed ID: 17680023 [TBL] [Abstract][Full Text] [Related]
20. [The analysis of failures in therapy of osteosarcoma in children treated according to SFOP-94 protocol in the studies of Polish pediatric solid tumors treatment group]. Chybicka A; Jaworski W; Liebhart M; Gołebiowski W; Kazanowska B; Wecławek-Tompol J; Woźniak W; Kowalczyk J; Katski K; Kołecki P; Boruczkowski D; Leda M Wiad Lek; 1998; 51 Suppl 4():40-4. PubMed ID: 10731942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]